Treatment Sequencing Strategies for R/R CLL: Impact of Prior 1L Therapy

Faculty share insights into the overall strategy for managing relapsed/refractory CLL following first-line therapy with venetoclax-based regimens and BTK inhibitors, discussing strategy variations based on prior first-line treatments.